In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week strongly. At the time of writing, the benchmark index is up 0.4% to 6,825.7 points.
Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:
Ampol Ltd (ASX: ALD)
The Ampol share price is tumbling 5% lower to $29.27. This morning Ampol announced the completion of its $300 million off-market buyback. The fuel retailer bought the shares back at $26.34, which represents a 14% discount. Ampol advised that it expects $24.33 of the buyback price to be treated as a fully franked dividend for Australian capital gains tax purposes.
Flight Centre Travel Group Ltd (ASX: FLT)
The Flight Centre share price is down 3% to $15.17. Flight Centre and a number of other travel shares have come under pressure today. This may have been driven by concerns that there could be delays to the rollout of COVID-19 vaccines in Australia.
Syrah Resources Ltd (ASX: SYR)
The Syrah share price has tumbled 6% lower to $1.23. This decline appears to have been driven by a broker note out of Credit Suisse this morning. According to the note, the broker has downgraded the graphite producer’s shares to a neutral rating with a price target of $1.25. Credit Suisse doesn’t believe graphite prices have recovered sufficiently to warrant the restart of its Balama operation just yet. It suspects it could happen in the final quarter of the year.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix share price is down 4% to $4.35. This is despite the release of a positive announcement this morning. That update reveals that the company has dosed the first patients from the phase 3 Zircon clinical trial. The Zircon (Zirconium Imaging in Renal Cancer Oncology) trial is a prospective imaging trial in approximately 250 renal cancer patients undergoing kidney surgery to determine the sensitivity and specificity of TLX250-CDx PET imaging to detect clear cell renal cell cancer (ccRCC).
This Tiny ASX Stock Could Be the Next Afterpay
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!
See how you can find out the name of this stock
Returns as of 6th October 2020
More reading
- ASX 200 up 0.35%: Afterpay & Appen push higher, big four banks rising
- Why the Telix (ASX:TLX) share price is dropping lower today
- The Syrah (ASX:SYR) share price is up 8% today. Here’s why
- Here are the 10 most shorted shares on the ASX
- Why the Ampol (ASX:ALD) share price is flat today
Motley Fool contributor James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Why Ampol, Flight Centre, Syrah, & Telix shares are dropping lower appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3oguHQu
Leave a Reply